Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Acute Toxicity: oral

Currently viewing:

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1984-04-03 to 1984-06-08
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
comparable to guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
1984
Report date:
1984

Materials and methods

Test guideline
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 401 (Acute Oral Toxicity)
Deviations:
no
GLP compliance:
yes
Test type:
standard acute method
Limit test:
no

Test material

Constituent 1
Chemical structure
Reference substance name:
Metformin hydrochloride
EC Number:
214-230-6
EC Name:
Metformin hydrochloride
Cas Number:
1115-70-4
Molecular formula:
C4H11N5.ClH
IUPAC Name:
N,N-dimethylimidodicarbonimidic diamide hydrochloride
Test material form:
solid: bulk
Specific details on test material used for the study:
Metformin Hydrochloride

Test animals

Species:
rat
Strain:
Sprague-Dawley
Sex:
male/female
Details on test animals or test system and environmental conditions:
TEST ANIMALS
- Source: Charles River
- Age at study initiation: young
- Weight at study initiation: 288.2g (males) and 216.4g (females)
- Fasting period before study: overnight
- Housing: single in mesh bottom cages
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: 7 days

ENVIRONMENTAL CONDITIONS
- Air changes (per hr): 12-15 / hour
- Photoperiod (hrs dark / hrs light): 12/12

IN-LIFE DATES: From: 1984-04-04 To: day 1984-04-24

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
water
Details on oral exposure:
VEHICLE
- Concentration in vehicle: 25 %

CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: dose range finding
Doses:
1000, 1320, 1730, 2280, 3000 mg/kg bw
No. of animals per sex per dose:
5 animals/sex/dose
Control animals:
no
Details on study design:
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: no
- Other examinations performed:
clinical signs: frequently during the day of dosing and then daily thereafter for 14 days
body weight: prior to dosing and after 7 and 14 days
gross necropsy to all animals dying during the 14-day observation period
Statistics:
Probit analysis was used for LD50 calculation.

Results and discussion

Effect levelsopen allclose all
Key result
Sex:
male/female
Dose descriptor:
LD50
Effect level:
1 770 mg/kg bw
Based on:
test mat.
95% CL:
> 1 510 - < 2 100
Sex:
female
Dose descriptor:
LD50
Effect level:
1 600 mg/kg bw
Based on:
test mat.
Sex:
male
Dose descriptor:
LD50
Effect level:
2 000 mg/kg bw
Based on:
test mat.
Mortality:
Mortality was observed starting at the lowest dose of 1000 mg/kg bw
Clinical signs:
other: decreased activity, ataxia, tremors, diarhea, salivation
Gross pathology:
no test item related leasions were reported

Applicant's summary and conclusion

Interpretation of results:
Category 4 based on GHS criteria
Conclusions:
In an oral toxicity study in rats equivalent to OECD 401, the acute oral LD50 of the test article for both sexes combined was calculated to be 1.77 g/kg body weight with a 95% confidence interval of 1.51 to 2.10 g/kg.
Executive summary:

The test material was evaluated for acute oral toxicity in male and female Sprague-Dawley rats. The substance was orally administered (gavage) dissolved in water as the vehicle to animals (5 per sex per group) at dose levels of 1000, 1320, 1730, 2280 and 3000 mg/kg bw. After administration, the rats were observed for mortality and clinical signs up to 14 days after treatment. All animals were weighed before treatment (day1) and therafter on day 8 and day 15. All animals dying during the study were subjected to a gross necropsy.

Mortalities were dose dependent and observed starting at the lowest dose of 1000 mg/kg bw. All deaths occurred within 24 hours following dose administration. Decreased activity, ataxia, tremors, diarrhea, salivation were noted as clinical signs.

Under the conditions of this study, the acute oral LD50 of the test article in rats in both sexes combined was calculated to be 1770 mg/kg bw (1,77 g/kg body weight) with a 95% confidence interval of 1,51 to 2,10 g/kg.